FIELD: medicine.
SUBSTANCE: invention relates to the use of bis(3,5-di-tert-butyl-4-hydroxyphenylthiolate)dimethylolol as a means to inhibit the metastasis of melanoma in the lungs.
EFFECT: reducing the frequency of development and the number of melanoma metastases in the lungs.
1 cl, 1 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PULMONARY METASTASIS INHIBITOR | 2021 |
|
RU2765955C1 |
| METHOD OF COMBINATION THERAPY OF B16 MELANOMA IN METRONOMIC MODE IN EXPERIMENT | 2022 |
|
RU2792561C1 |
| MEANS FOR INHIBITION OF METASTASIS IN LUNGS | 2016 |
|
RU2632703C1 |
| ANTINEOPLASTIC AGENT | 2016 |
|
RU2623034C1 |
| METHOD FOR ACHIEVING ANTIMETASTATIC EFFECT IN EXPERIMENT | 2017 |
|
RU2661704C1 |
| METHOD FOR ENHANCING ANTIMETASTATIC ACTION OF CISPLATIN AND REDUCING ITS SIDE EFFECT ON HAEMOSTASIS SYSTEM | 2023 |
|
RU2825825C1 |
| METHOD FOR SUPPRESSING THE GROWTH OF B16 MELANOMA IN LABORATORY ANIMALS | 2022 |
|
RU2784443C2 |
| DRUG WITH ANTIPROLIFERATIVE AND ANTIMETASTATIC EFFECTS AGAINST LEWIS LUNG CARCINOMA WHEN INJECTED INTRAPERITONEALLY | 2022 |
|
RU2792144C1 |
| PHARMACEUTICAL COMPOSITION BASED ON PALLADIUM COMPOUND | 2015 |
|
RU2613305C2 |
| ANTIMETASTATIC COMPOSITION | 2006 |
|
RU2308966C1 |
Authors
Dates
2021-12-22—Published
2021-03-30—Filed